Published in Nature on April 05, 2001
Loading-rate-independent delay of catastrophic avalanches in a bulk metallic glass. Sci Rep (2016) 0.89
Earthquake-like dynamics in Myxococcus xanthus social motility. Proc Natl Acad Sci U S A (2013) 0.87
Probing the character of ultra-fast dislocations. Sci Rep (2015) 0.84
Universality of slip avalanches in flowing granular matter. Nat Commun (2016) 0.82
Quasi-periodic events in crystal plasticity and the self-organized avalanche oscillator. Nature (2012) 0.82
Evolution of the average avalanche shape with the universality class. Nat Commun (2013) 0.82
Scaling description of the yielding transition in soft amorphous solids at zero temperature. Proc Natl Acad Sci U S A (2014) 0.81
Deformation and failure of curved colloidal crystal shells. Proc Natl Acad Sci U S A (2015) 0.80
Flaw-induced plastic-flow dynamics in bulk metallic glasses under tension. Sci Rep (2016) 0.75
The Portevin-Le Chatelier effect: a review of experimental findings. Sci Technol Adv Mater (2011) 0.75
Dynamic phases, pinning, and pattern formation for driven dislocation assemblies. Sci Rep (2015) 0.75
Linking scales in sea ice mechanics. Philos Trans A Math Phys Eng Sci (2017) 0.75
Quenched pinning and collective dislocation dynamics. Sci Rep (2015) 0.75
Acoustic Emission of Deformation Twinning in Magnesium. Materials (Basel) (2016) 0.75
Epidemic spreading in scale-free networks. Phys Rev Lett (2001) 18.02
The architecture of complex weighted networks. Proc Natl Acad Sci U S A (2004) 11.53
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
Dynamical and correlation properties of the internet. Phys Rev Lett (2001) 6.05
Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem (1978) 4.61
Epidemic dynamics and endemic states in complex networks. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 3.83
Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem (1979) 3.15
Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. J Clin Invest (1980) 2.99
Competition among memes in a world with limited attention. Sci Rep (2012) 2.98
The decision to breastfeed in the United States: does race matter? Pediatrics (2001) 2.67
Intracellular Ca(2+) dynamics and the stability of ventricular tachycardia. Biophys J (1999) 2.65
Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology (2002) 2.49
A reevaluation of the roles of the O2-dependent and O2-independent microbicidal systems of phagocytes. Rev Infect Dis (1983) 2.35
Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30
Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29
Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem (1989) 2.29
Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol (2012) 2.20
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J Clin Invest (1975) 2.16
A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions. Clin Pharmacol Ther (2013) 2.15
The modeling of global epidemics: stochastic dynamics and predictability. Bull Math Biol (2006) 2.12
Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events. J Am Coll Cardiol (1996) 2.09
Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest (1985) 2.05
Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system. J Clin Invest (1982) 2.04
An evolving view of Saturn's dynamic rings. Science (2010) 1.99
Latex sensitization in health care workers and in the US general population. Am J Epidemiol (2001) 1.98
Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem (2001) 1.98
Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. J Clin Invest (1983) 1.93
Nonclassical estrogen receptor alpha signaling mediates negative feedback in the female mouse reproductive axis. Proc Natl Acad Sci U S A (2007) 1.86
A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J Biol Chem (1987) 1.86
Early and discrete changes in permeability of Escherichia coli and certain other gram-negative bacteria during killing by granulocytes. J Exp Med (1974) 1.82
Life-support system benefits from noise. Nature (1998) 1.81
Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med (1991) 1.80
A simple method for measuring red cell deformability in models of the microcirculation. Blut (1973) 1.75
Activity driven modeling of time varying networks. Sci Rep (2012) 1.74
Prevention of pedestrian injuries to children: effectiveness of a school training program. Pediatrics (1991) 1.72
Web-based participatory surveillance of infectious diseases: the Influenzanet participatory surveillance experience. Clin Microbiol Infect (2014) 1.70
The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol (1984) 1.67
Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood (1987) 1.66
Acceleration of wound healing by topical application of honey. An animal model. Am J Surg (1983) 1.66
Source of bias in prenatal care utilization indices: implications for evaluating the Medicaid expansion. Am J Public Health (1991) 1.63
Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival. JAMA (1981) 1.62
Heart rate variability. Frequency domain analysis. Cardiol Clin (1992) 1.60
Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia (1998) 1.56
Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 1.56
The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest (1996) 1.54
Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J Clin Invest (1990) 1.52
Antimicrobial peptides of phagocytes and epithelia. Semin Hematol (1997) 1.50
Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes. J Clin Invest (1985) 1.50
Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol (1998) 1.49
Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins. J Biol Chem (1993) 1.48
The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology (1993) 1.48
Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil bactericidal/permeability-increasing protein. Infect Immun (1986) 1.48
Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. J Immunol (1989) 1.44
Selective block of urethral sphincter contraction using a modified Brindley electrode in sacral anterior root stimulation of the dog. Neurourol Urodyn (2002) 1.43
Isolation and characterization of a phospholipase A2 from an inflammatory exudate. J Lipid Res (1978) 1.42
Bidirectional movement of a nascent polypeptide across microsomal membranes reveals requirements for vectorial translocation of proteins. Cell (1992) 1.41
Detection of fungi in tissue sections by lectin histochemistry. Arch Pathol Lab Med (1988) 1.41
Reversible envelope effects during and after killing of Escherichia coli w by a highly-purified rabbit polymorpho-nuclear leukocyte fraction. Biochim Biophys Acta (1976) 1.39
[SAPHO syndrome. Case description of 3 patients with acne conglobata and osteoarticular symptoms]. Hautarzt (1997) 1.38
Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli. J Clin Invest (1994) 1.34
Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. Radiology (1994) 1.33
A tail electrode for unrestrained rats. J Exp Anal Behav (1967) 1.33
Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect Immun (1997) 1.33
Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int (2002) 1.33
Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology (1995) 1.33
Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J Biol Chem (1990) 1.32
Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol (1994) 1.31
Dorsoventral patterning in the Drosophila central nervous system: the vnd homeobox gene specifies ventral column identity. Genes Dev (1998) 1.30
Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis (2011) 1.30
Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest (1995) 1.29
Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959. Lancet (1986) 1.26
Construction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions. J Biol Chem (2000) 1.26
Influence of nuclear selection criteria on sex chromatin frequency in oral mucosa cells of newborn females. Cytogenetics (1967) 1.25
Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin. Curr Opin Immunol (1993) 1.23
Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli. Proc Natl Acad Sci U S A (1981) 1.23
Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol (2000) 1.22
Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic. Euro Surveill (2014) 1.20
Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils. Infect Immun (1982) 1.19
An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci U S A (1997) 1.19
Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J Clin Invest (1990) 1.18
Shame, guilt, and depression in men and women in recovery from addiction. J Subst Abuse Treat (1995) 1.18
Emulsion-based delivery systems for lipophilic bioactive components. J Food Sci (2007) 1.18
Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem (1997) 1.17
Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res (1994) 1.17
Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases. J Clin Invest (1990) 1.16
Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Am J Cardiol (1982) 1.16
Preterm birth prevention: an evaluation of programs in the United States. Birth (1991) 1.16
Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. J Clin Invest (1998) 1.15
Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein. J Immunol (1993) 1.15
The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int (2002) 1.14
Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol (1984) 1.13
Antimicrobial activity of ultrasound-assisted solvent-extracted spices. Lett Appl Microbiol (2004) 1.12
Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J Colloid Interface Sci (2009) 1.12
The use of a phospholipase A-less Escherichia coli mutant to establish the action of granulocyte phospholipase A on bacterial phospholipids during killing by a highly purified granulocyte fraction. Biochim Biophys Acta (1977) 1.12
Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry (1986) 1.11
Mouse endometrial stromal cells produce basement-membrane components. Differentiation (1986) 1.11
Utilization of labeled Escherichia coli as phospholipase substrate. Methods Enzymol (1991) 1.10